DOPTELET
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 17 Oct 2024)
What this means for you
Registered since 28 Aug 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87501538
- Registration number
- 5551985
- Mark type
- Design + words
- Filed
- 22 Jun 2017
- Published for opposition
- 28 Nov 2017
- Registered
- 28 Aug 2018
- Attorney of record
- Theodore A. Breiner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of thrombocytopenia disease
Owner
- AkaRx, Inc., Morrisville, NC, US
- AkaRx, Inc., Charlottesville, VA, US
- AkaRx, Inc., Charlottesville, VA, US
Prior registrations
Prosecution history
- 17 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Oct 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Apr 2024 — TEAS SECTION 8 & 15 RECEIVED
- 28 Aug 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Nov 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Nov 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Aug 2018 — REGISTERED-PRINCIPAL REGISTER
- 24 Jul 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Jul 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Jun 2018 — USE AMENDMENT FILED
- 19 Jul 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jun 2018 — TEAS STATEMENT OF USE RECEIVED
- 23 Jan 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT